Marker-free coselection for CRISPR-driven genome editing in human cells-Reference-Cited by-同舟云学术

Marker-free coselection for CRISPR-driven genome editing in human cells

Published:2017-04-17 Issue:6 Volume:14 Page:615-620
ISSN:1548-7091
Container-title:Nature Methods
language:en
Short-container-title:Nat Methods

Author:

Agudelo Daniel,Duringer Alexis,Bozoyan Lusiné,Huard Caroline C,Carter Sophie^ORCID,Loehr Jeremy,Synodinou Dafni,Drouin Mathieu,Salsman Jayme,Dellaire Graham^ORCID,Laganière Josée^ORCID,Doyon Yannick^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology,Biochemistry,Biotechnology

Link

http://www.nature.com/articles/nmeth.4265.pdf

Reference48 articles.

1. Hsu, P.D., Lander, E.S. & Zhang, F. Development and applications of CRISPR-Cas9 for genome engineering. Cell 157, 1262–1278 (2014).

2. Joung, J.K. & Sander, J.D. TALENs: a widely applicable technology for targeted genome editing. Nat. Rev. Mol. Cell Biol. 14, 49–55 (2013).

3. Urnov, F.D., Rebar, E.J., Holmes, M.C., Zhang, H.S. & Gregory, P.D. Genome editing with engineered zinc finger nucleases. Nat. Rev. Genet. 11, 636–646 (2010).

4. Tycko, J., Myer, V.E. & Hsu, P.D. Methods for optimizing CRISPR-Cas9 genome editing specificity. Mol. Cell 63, 355–370 (2016).

5. Doench, J.G. et al. Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9. Nat. Biotechnol. 34, 184–191 (2016).

Cited by 142 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structural insights into the human NuA4/TIP60 acetyltransferase and chromatin remodeling complex;Science;2024-08-23

2. Control of Intestinal Stemness and Cell Lineage by Histone Variant H2A.Z Isoforms;Molecular and Cellular Biology;2024-08-18

3. Enrichment of prime-edited mammalian cells with surrogate Puro reporters;International Journal of Biological Macromolecules;2024-06

4. TDP1 mutation causing SCAN1 neurodegenerative syndrome hampers the repair of transcriptional DNA double-strand breaks;Cell Reports;2024-05

5. A glycolytic metabolite bypasses “two-hit” tumor suppression by BRCA2;Cell;2024-04